ResMed Inc. (RMD) reported results for its quarter ended June 30, 2018. ResMed's revenue increased 12% to $623.6 million (up 10% on a constant currency basis), net income increased by 8% and non-GAAP net income surged 24% compared to the same period of the prior year. The company closed out the year with strong performance across all aspects of its business, from solid top-line revenue growth - driven by geographically balanced results across its entire portfolio of offerings - to continued improvements in operating leverage, which has resulted in double-digit bottom-line growth.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)